MX2020007214A - Composiciones para usar en la promocion del crecimiento y desarrollo de los musculos intestinales y la motilidad intestinal asociada. - Google Patents

Composiciones para usar en la promocion del crecimiento y desarrollo de los musculos intestinales y la motilidad intestinal asociada.

Info

Publication number
MX2020007214A
MX2020007214A MX2020007214A MX2020007214A MX2020007214A MX 2020007214 A MX2020007214 A MX 2020007214A MX 2020007214 A MX2020007214 A MX 2020007214A MX 2020007214 A MX2020007214 A MX 2020007214A MX 2020007214 A MX2020007214 A MX 2020007214A
Authority
MX
Mexico
Prior art keywords
promotion
intestinal
development
compositions
motility
Prior art date
Application number
MX2020007214A
Other languages
English (en)
Inventor
Clara Lucia Garcia-Rodenas
Myriam Sandrine Steinmann
Nieves José Manuel Ramos
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of MX2020007214A publication Critical patent/MX2020007214A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pediatric Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Esta invención se relaciona con composiciones nutricionales que comprenden al menos un oligosacárido N-acetilado para usar en la promoción del desarrollo y/o del crecimiento de los músculos intestinales, en la promoción de la capacidad contráctil y/o la motilidad en el intestino, en la promoción de la tolerancia a la alimentación entérica y en la prevención y/o el tratamiento de la hiperproliferación bacteriana del intestino delgado (SIBO) en un infante, un niño pequeño o, cuando la composición es una leche de crecimiento, en un niño.
MX2020007214A 2017-12-21 2018-12-20 Composiciones para usar en la promocion del crecimiento y desarrollo de los musculos intestinales y la motilidad intestinal asociada. MX2020007214A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17209479 2017-12-21
PCT/EP2018/086301 WO2019122190A1 (en) 2017-12-21 2018-12-20 Compositions for use in the promotion of intestinal muscle growth and development and associated intestinal motility

Publications (1)

Publication Number Publication Date
MX2020007214A true MX2020007214A (es) 2020-09-07

Family

ID=60954738

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020007214A MX2020007214A (es) 2017-12-21 2018-12-20 Composiciones para usar en la promocion del crecimiento y desarrollo de los musculos intestinales y la motilidad intestinal asociada.

Country Status (9)

Country Link
US (1) US20210008086A1 (es)
EP (1) EP3727399A1 (es)
CN (1) CN111479573B (es)
AU (1) AU2018387291A1 (es)
BR (1) BR112020008724A2 (es)
CL (1) CL2020001196A1 (es)
MX (1) MX2020007214A (es)
PH (1) PH12020550464A1 (es)
WO (1) WO2019122190A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020128948A1 (en) * 2018-12-21 2020-06-25 Glycom A/S Composition and method for promoting intestinal barrier healing
US20240033276A1 (en) * 2020-12-04 2024-02-01 Societe Des Produits Nestle S.A. Composition for preterm infants to reduce time to full enteral feeding
EP4255198A1 (en) * 2020-12-04 2023-10-11 Société des Produits Nestlé S.A. Stable aqueous composition for preterm to promote early postnal growth
WO2022225786A1 (en) * 2021-04-22 2022-10-27 Abbott Laboratories Methods and compositions for improving muscle strength and/or reducing muscle loss

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180674A (en) 1990-04-16 1993-01-19 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5545553A (en) 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
PL1993576T3 (pl) * 2006-03-07 2016-04-29 Nestec Sa Mieszanina synbiotyczna
CN107822150A (zh) 2009-11-30 2018-03-23 株式会社明治 对小肠有益的营养组合物
EP2658547A1 (en) * 2010-12-31 2013-11-06 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
WO2012092155A1 (en) * 2010-12-31 2012-07-05 Abbott Laboratories Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
US20140286908A1 (en) * 2011-10-18 2014-09-25 Nestec S.A. Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery
CN103372021B (zh) 2013-07-04 2015-08-12 丁圣雨 Chukrasone A在制备促进小肠蠕动药物中的应用
ES2916813T3 (es) * 2013-11-15 2022-07-06 Nestle Sa Composiciones para uso en la prevención o tratamiento de enterocolitis necrotizante en lactantes y niños pequeños

Also Published As

Publication number Publication date
US20210008086A1 (en) 2021-01-14
RU2020115239A (ru) 2021-11-01
CN111479573A (zh) 2020-07-31
CL2020001196A1 (es) 2020-10-02
EP3727399A1 (en) 2020-10-28
BR112020008724A2 (pt) 2020-11-03
RU2020115239A3 (es) 2022-04-14
PH12020550464A1 (en) 2021-03-15
WO2019122190A1 (en) 2019-06-27
AU2018387291A1 (en) 2020-05-07
CN111479573B (zh) 2024-05-24

Similar Documents

Publication Publication Date Title
PH12020550464A1 (en) Compositions for use in the promotion of intestinal muscle growth and development and associated intestinal motility
MX2022013835A (es) Produccion sinergica de butirato asociada con la complejidad de la mezcla de hmo para usar en infantes o niños pequeños en con fines de salud.
PH12017502350A1 (en) Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
PH12017500174A1 (en) INFANT FORMULA SYSTEM WITH ADAPTIVE LEVELS OF HUMAN MILK OLIGOSACCHARIDES (HMOs)
PH12017550040A1 (en) Compositions for use in the prevention or treatment of gastrointestinal infections/inflammations in infants or young children
PH12017550044A1 (en) Compositions for use in the prevention or treatment of otitis or bronchitis in infants or young children
PH12018501328A1 (en) Compositions comprising 2fl and lnnt for use in infants or young children to prevent later in life obesity or related comorbidities
MX2018008955A (es) Composiciones que comprenden oligosacaridos de la leche humana para usar en infantes o niños pequeños para prevenir o tratar un trastorno de la salud al aumentar la secrecion de glp-1.
PH12019550208A1 (en) Hmos blends for use in infants or young children for health purposes
PH12018501263A1 (en) Compositions comprising sialylated oligosaccharides for use in infants or young children to prevent later in life obesity or related comorbidities and promote a healthy growth
MX2022011167A (es) Metodos para mejorar las respuestas inmune innata y/o deteccion de patogenos de la mucosa mediante oligosacaridos de la leche humana.
PH12018501324A1 (en) COMPOSITIONS COMPRISING 2FL AND LNnT TO CONTROL FOOD INTAKE AND GROWTH IN INFANTS OR YOUNG CHILDREN
PH12018501298A1 (en) Human milk oligosaccharides for health benefits by prevention of premature adiposity rebound
PH12017502182A1 (en) Nutritional compositions and infant formulas comprising bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
MX2019011445A (es) Composicion que comprende oligosacaridos de la leche humana (hmo) para usar en la mejora de la memoria a corto plazo y otros beneficios cognitivos.
NZ771554A (en) Nutritional composition for promoting intestinal health
PH12018501262A1 (en) Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat allergies
MX2017001569A (es) Formulaciones de suspención oral en polvo de agentes antibacterianos.
MY183171A (en) Composition containing bacterium belonging to genus lactobacillus
ZA202004246B (en) Compositions comprising at least on n-acetylated and at least one fucosylated oligosaccharide for use in the promotion of digestive capacity in infants and young children
PH12019500092A1 (en) Nutritional compositions for infants and/or young children comprising oligosaccharides
PH12017501953A1 (en) Nutritional compositions and infant formulas containing oligofructose for reducing the load of pathogenic bacteria in the guts of infants and young children
MX2019002386A (es) Uso de oligosacaridos de leche humana en el engorde de terneros.
PH12017500466A1 (en) Nutritional compositions comprising sn-1(3) monoacylglycerols for use in the treatment of growth delay in infants or children
EP4321211A3 (en) Nutritional composition comprising urea and non-digestible oligosaccharides